Talk:Marathon Pharmaceuticals

Each drug has value for specific patients, so even if these drugs are older, the company is still "noteable." What's "noteable" is in the eye of the beholder. I follow this company because of the drugs for severely disabled patients with Duchenne muscular dystrophy that they are in the process of bringing forward. There are no meds now for these patients so the fact that they are developing one does indeed make them "noteable."

SpartanSister (talk) 22:38, 14 July 2014 (UTC)